Sensus Healthcare, Inc.
SRTS Healthcare Medical Devices
Sensus Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $27.5 million, down 34.3% from fiscal 2024. In the quarter to June 2026, revenue fell 68.7%, EPS fell 783.3% and free cash flow fell 201.7%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow SRTS
Sensus Healthcare, Inc. (SRTS) Altman Z-score
Sensus Healthcare, Inc.'s Altman Z-score for fiscal 2025 is 8.85, in the safe zone (above 2.99).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2025 | 8.85 | (4.22) |
| FY2024 | 13.07 | 6.72 |
| FY2023 | 6.35 | (4.88) |
| FY2022 | 11.23 | (1.65) |
| FY2021 | 12.89 | 7.91 |
| FY2020 | 4.98 | 0.24 |
| FY2019 | 4.74 | (5.46) |
| FY2018 | 10.20 | 4.06 |
| FY2017 | 6.14 | (5.14) |
| FY2016 | 11.29 | — |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | 0.78 | — | 0.93 | |
| Retained earnings / total assets | 0.11 | — | 0.15 | |
| EBIT / total assets | (0.19) | — | −0.64 | |
| Market value of equity / total liabilities | 13.15 | — | 7.89 | |
| Sales / total assets | 0.52 | — | 0.52 | |
| Altman Z-score | Safe zone | 8.85 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Safe zone | 14.36 | ||
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| SRTS Sensus Healthcare, Inc. | 8.9× |
| XTNT Xtant Medical Holdings, Inc. compare | 0.0× |
| SNWV Sanuwave Health Inc. compare | −3.0× |
| MYO Myomo, Inc. compare | −3.0× |
| MDAI Spectral AI, Inc. compare | −3.3× |
| TELA TELA Bio, Inc. compare | −5.9× |
| RPID Rapid Micro Biosystems, Inc. compare | −8.9× |
| TLIS Talis Biomedical Corporation compare | −9.1× |
| COCH Envoy Medical, Inc. compare | −60.1× |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets